All posts in
A New Peptide Vaccine for Multiple Sclerosis Succeeds in Phase IIa
New Immunotherapy Candidate receives FDA Fast Track Designation
Actelion’s key Drug linked to Deaths, prompting EMA Investigation
Suffering from House Dust Mite Allergy? A New Therapy is on its Way
Which European Country is Winning the Race in Clinical Development?
To the Rescue: A Final Phase III Success for Post-Operative Nausea
The FDA lays down Laws of Interchangeability: New Era for Biosimilars?
Galapagos kicks off a Phase IIa trial for Cystic Fibrosis
World Cancer Day is Saturday! Europe’s Oncology in Numbers
I heard about these Hot Topics at JPM: Devices, Politics & Personalities
New Combo Therapy for Type 2 Diabetes to Sweep Europe
It’s Not Just Regulations: 9 Other Reasons Advanced Therapies Fail
Labiotech UG, All Rights Reserved -
Send this to friend